ClinicalTrials.gg
Status unknownNCT03786211Updated Dec 24, 2018

IANB Success Rate With and Without Panoramic Help

A Phase 2/3 interventional study of IANB by the guide of Panoramic and IANB without the guide of Panoramic in Anesthesia and Anesthesia; Functional, sponsored by Hormozgan University of Medical Sciences. Status unknown at 1 site in Iran, Islamic Republic of. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-12-24.

Sponsored by Hormozgan University of Medical Sciences · Phase 2/3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 2/3
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Since it is difficult to achieve anesthesia in lower jaw and the success rate of IANB is low and there are a lot of anatomic variations for the location of inferior alveolar nerve in different races, investigators decided to compare the success rate of inferior alveolar nerve block, with and without using a panoramic radiograph in Bandar Abbas population, and see if using a panoramic radiograph can increase the preciseness of the injection.

Read the detailed description

This is a double blinded cross-over randomized controlled trial study conducted on all the patients of the dental clinic indicated for bilateral extraction or filling.

The randomization method is block balanced randomization. All patients will ask to fulfill the ethical Form. This form acquired demographic information (e.g. age, sex) about patients. A panoramic radiograph will take from those who matched the inclusion criteria and signed the agreement. Then a tooth from one side will be treated and the tooth from the other side of the mouth will treat at least 2 weeks later by the same dentist.

02

Conditions studied

  • Anesthesia
  • Anesthesia; Functional

Keywords

  • Mandible
  • Anesthesia
03

In context

Lead sponsor

Hormozgan University of Medical Sciences is the lead sponsor of 23 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients indicated for bilateral tooth extractions of fillings.
  • Physically and mentally healthy patients who could express their pain.
  • having panoramic radiograph from the past six months for other dental purposes.

Exclusion criteria

Exclusion Criteria:

  • sensitive to the regular anesthetics containing epinephrine.
  • patients with acute or chronic pericoronitis.
  • pregnancy
  • trismus
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    IANB without panoramic

    They will get Ianb without using panoramic

    Procedure: IANB by the guide of Panoramic · Procedure: IANB without the guide of Panoramic

  • Experimental
    IANB with panoramic

    They will get IANB by the guide of panoramic

    Procedure: IANB by the guide of Panoramic · Procedure: IANB without the guide of Panoramic

Interventions

  • ProcedureIANB by the guide of Panoramic

    IANB will be injected by the guide of panoramic radiograph

  • ProcedureIANB without the guide of Panoramic

    IANB will be injected without the guide of panoramic radiograph, in the routine way.

06

What researchers measure

Primary outcomes

  1. Number of participants with good Anesthesia

    Time frame: 30 minutes after injection

07

Study locations

1 of 1 sites recruiting
  • Dental clinic of BandarAbbas faculty of dentistry
    BandarAbbas, Hormozgan, Iran, Islamic Republic of
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2018 (actual). Primary completion is estimated for Jan 2019, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 8, 2018
First posted
Dec 24, 2018
StartActual
Nov 12, 2018
Primary completionEst.
Jan 2019
CompletionEst.
Feb 2019
Last update
Dec 24, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03786211
Lead sponsor
Hormozgan University of Medical Sciences
Responsible party
Sajad Ansari Fard (PhD, Student research committee, Hormozgan University of Medical Sciences) — Principal investigator
First posted
Dec 24, 2018
Start date
Nov 12, 2018
Primary completion
Jan 2019 (estimated)
Completion
Feb 2019 (estimated)
Last update
Dec 24, 2018

Study contacts

Sajad Ansarifard, DDS, PhD
Contact
Sajad.ansarifard@hums.ac.ir
?989366584476
Hossein Dabbagh
Contact
hossein.dabagh@hums.ac.ir
Hossein Dabbagh, Md, PhD
study chair · Persian Gulf Oral and Dental Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion